Vancomycin Dosing and Monitoring in the Treatment of Cystic Fibrosis: Results of a National Practice Survey

OBJECTIVES: Vancomycin is commonly used in patients with cystic fibrosis (CF) to treat acute pulmonary exacerbations, but few guidelines exist to help dose and monitor patients. The objective of this study was to assess vancomycin use and monitoring strategies at Cystic Fibrosis Foundation (CFF)–acc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pediatr Pharmacol Ther
Autors principals: Pettit, Rebecca S., Peters, Stacy J., McDade, Erin J., Kreilein, Kaci, Patel, Radha, Epps, Kevin, Kittell, Frederick, Duval, Mariela A., Zobell, Jeffery T.
Format: Artigo
Idioma:Inglês
Publicat: Pediatric Pharmacy Advocacy Group 2017
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736252/
https://ncbi.nlm.nih.gov/pubmed/29290740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-22.6.406
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars